Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doruk Erkan

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Annual Review of Medicine|January 19, 2017
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal DiseaseOzan Unlu, Doruk Erkan
Current Opinion in Pharmacology|May 31, 2022
Treatment advances in antiphospholipid syndrome: 2022 updateZeynep Belce Erton, Doruk Erkan
Current Rheumatology Reports|November 6, 2004
What is antiphospholipid syndrome?Doruk Erkan, Michael D Lockshin
Expert Review of Hematology|April 4, 2013
Could statins be a new therapeutic option for antiphospholipid syndrome patients?Doruk Erkan, Silvia S Pierangeli
The New England Journal of Medicine|September 19, 2003
Treatment of the antiphospholipid syndromeMichael D Lockshin, Doruk Erkan
Rheumatic Diseases Clinics of North America|March 1, 2006
New treatments for antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Thrombosis Research|October 28, 2004
How much warfarin is enough in APS related thrombosis?Doruk Erkan, Michael D Lockshin
Current Opinion in Rheumatology|April 4, 2006
Antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Nature Clinical Practice. Rheumatology|March 3, 2009
New approaches for managing antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Therapeutic Advances in Musculoskeletal Disease|December 3, 2013
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal diseaseCassyanne L Aguiar, Doruk Erkan
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Annual Review of Medicine|January 19, 2017
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal DiseaseOzan Unlu, Doruk Erkan
Current Opinion in Pharmacology|May 31, 2022
Treatment advances in antiphospholipid syndrome: 2022 updateZeynep Belce Erton, Doruk Erkan
Current Rheumatology Reports|November 6, 2004
What is antiphospholipid syndrome?Doruk Erkan, Michael D Lockshin
Expert Review of Hematology|April 4, 2013
Could statins be a new therapeutic option for antiphospholipid syndrome patients?Doruk Erkan, Silvia S Pierangeli
The New England Journal of Medicine|September 19, 2003
Treatment of the antiphospholipid syndromeMichael D Lockshin, Doruk Erkan
Rheumatic Diseases Clinics of North America|March 1, 2006
New treatments for antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Thrombosis Research|October 28, 2004
How much warfarin is enough in APS related thrombosis?Doruk Erkan, Michael D Lockshin
Current Opinion in Rheumatology|April 4, 2006
Antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Nature Clinical Practice. Rheumatology|March 3, 2009
New approaches for managing antiphospholipid syndromeDoruk Erkan, Michael D Lockshin
Therapeutic Advances in Musculoskeletal Disease|December 3, 2013
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal diseaseCassyanne L Aguiar, Doruk Erkan
Pageof 20